<DOC>
	<DOCNO>NCT01901575</DOCNO>
	<brief_summary>Determine effect remifentanil conscious sedation patient undergoing Electrophysiological ( EP ) study ablation idiopathic ventricular tachycardia and/or persistent frequent premature ventricular contraction ( PVCs ) non-ischemic origin</brief_summary>
	<brief_title>Remifentanil Intravenous Patient Controlled Analgesia ( IVPCA ) Ablation Idiopathic Ventricular Tachycardia</brief_title>
	<detailed_description>The purpose study determine effect remifentanil conscious sedation patient undergoing Electrophysiological ( EP ) study ablation idiopathic ventricular tachycardia and/or persistent frequent PVCs non-ischemic origin . Remifentanil analgesic- synthetic opiate short half life . It rapidly break enzyme blood ideally suit continuous sedation . The effect practically eliminate within 5 minute intravenous sedation stop . You ask participate study already schedule undergo EP study care cardiologist ablation idiopathic ventricular tachycardia and/or persistent frequent PVCs non-ischemic origin .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Patients schedule undergo EP study ablation idiopathic ventricular tachycardia and/or persistent frequent PVCs nonischemic origin Patients 18 65 ASA 13 ASA 4 5 Age 18 65</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>idiopathic ventricular tachycardia</keyword>
</DOC>